630 related articles for article (PubMed ID: 24166518)
1. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
[TBL] [Abstract][Full Text] [Related]
2. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
3. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
[TBL] [Abstract][Full Text] [Related]
4. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
5. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
[TBL] [Abstract][Full Text] [Related]
6. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma.
Park MJ; Taki T; Oda M; Watanabe T; Yumura-Yagi K; Kobayashi R; Suzuki N; Hara J; Horibe K; Hayashi Y
Br J Haematol; 2009 Apr; 145(2):198-206. PubMed ID: 19245433
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
[TBL] [Abstract][Full Text] [Related]
8. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Jenkinson S; Kirkwood AA; Goulden N; Vora A; Linch DC; Gale RE
Leukemia; 2016 Jan; 30(1):39-47. PubMed ID: 26220040
[TBL] [Abstract][Full Text] [Related]
9. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Ben Abdelali R; Asnafi V; Leguay T; Boissel N; Buzyn A; Chevallier P; Thomas X; Lepretre S; Huguet F; Vey N; Escoffre-Barbe M; Tavernier E; Reman O; Fegueux N; Turlure P; Rousselot P; Cahn JY; Lheritier V; Chalandon Y; Béné MC; Macintyre E; Dombret H; Ifrah N;
Blood; 2011 Nov; 118(19):5099-107. PubMed ID: 21835957
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
[TBL] [Abstract][Full Text] [Related]
11. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Larson Gedman A; Chen Q; Kugel Desmoulin S; Ge Y; LaFiura K; Haska CL; Cherian C; Devidas M; Linda SB; Taub JW; Matherly LH
Leukemia; 2009 Aug; 23(8):1417-25. PubMed ID: 19340001
[TBL] [Abstract][Full Text] [Related]
12. Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia.
Mansur MB; Hassan R; Barbosa TC; Splendore A; Jotta PY; Yunes JA; Wiemels JL; Pombo-de-Oliveira MS
BMC Cancer; 2012 Jan; 12():9. PubMed ID: 22225590
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.
Fogelstrand L; Staffas A; Wasslavik C; Sjögren H; Söderhäll S; Frost BM; Forestier E; Degerman S; Behrendtz M; Heldrup J; Karrman K; Johansson B; Heyman M; Abrahamsson J; Palmqvist L
Pediatr Blood Cancer; 2014 Mar; 61(3):424-30. PubMed ID: 24424791
[TBL] [Abstract][Full Text] [Related]
14. NOTCH1 and FBXW7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.
Natarajan V; Bandapalli OR; Rajkumar T; Sagar TG; Karunakaran N
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e23-30. PubMed ID: 25493453
[TBL] [Abstract][Full Text] [Related]
15. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
[TBL] [Abstract][Full Text] [Related]
16. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
Clappier E; Collette S; Grardel N; Girard S; Suarez L; Brunie G; Kaltenbach S; Yakouben K; Mazingue F; Robert A; Boutard P; Plantaz D; Rohrlich P; van Vlierberghe P; Preudhomme C; Otten J; Speleman F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2010 Dec; 24(12):2023-31. PubMed ID: 20861920
[TBL] [Abstract][Full Text] [Related]
17. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
[TBL] [Abstract][Full Text] [Related]
18. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.
Sakhdari A; Thakral B; Loghavi S; Kanagal-Shamanna R; Yin CC; Zuo Z; Routbort MJ; Luthra R; Medeiros LJ; Wang SA; Patel KP; Ok CY
Cancer Med; 2020 Feb; 9(3):849-858. PubMed ID: 31804006
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia.
Baldus CD; Thibaut J; Goekbuget N; Stroux A; Schlee C; Mossner M; Burmeister T; Schwartz S; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
Haematologica; 2009 Oct; 94(10):1383-90. PubMed ID: 19794083
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway.
Gallo Llorente L; Luther H; Schneppenheim R; Zimmermann M; Felice M; Horstmann MA
Pediatr Blood Cancer; 2014 May; 61(5):788-96. PubMed ID: 24249312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
